Skip to main content

Marta Ribases Haro

Institutions of which they are part

Main researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Marta Ribases Haro

Institutions of which they are part

Main researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Projects

Sol·licitud Juan de la Cierva-Incorporació

IP: Marta Ribases Haro
Collaborators: Maria Soler Artigas
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 93000
Reference: IJC2018-035346-I
Duration: 01/05/2020 - 31/12/2022

Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in IRritable bowel syndrome In Europe (DISCOvERIE)

IP: Fco Javier Santos Vicente
Collaborators: Beatriz Lobo Alvarez, Silvia Muñoz Caller, Carmen Alonso Cotoner, Ana Maria Gonzalez Castro, Elba Exposito Fernandez, Marc Pigrau Pastor, Adoración Nieto Ruiz, Alejandro Henao Paez, Consuelo Cammarota, José Alegre Martin, Jesus Castro Marrero, Marta Ribases Haro, Natalia Llonga Tejedor, Amanda Rodríguez Urrutia
Funding agency: EUROPEAN COMMISSION
Funding: 1148684.84
Reference: DISCOVERIE_H2020-SC1-BHC2019
Duration: 01/01/2020 - 31/05/2025

FPII per Psiquiatría, Salud Mental i Adiccions

IP: Marta Ribases Haro
Collaborators: Laia Perez Lasarte
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 35800
Reference: PEJ2018-004779-A
Duration: 01/08/2019 - 31/07/2021

Pendent

IP: Marta Ribases Haro
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 82400
Reference: FI18/00285
Duration: 09/01/2019 - 08/06/2023

Related news

A study led by the Vall d'Hebron Research Institute and the Sant Joan de Déu Research Institute shows that environmental pollution increases the risk of emotional problems, while the presence of green spaces near the school reduces behavioural disorders.

The doctoral training program of excellence led by the UAB TOUCH MSCA-COFUND, focused on the field of mental health, opens its second call until March 31.

Irritability in ADHD and BDP is an understudied symptom that has a major impact on patients' quality of life and may even increase the risk of suicide.

Related professionals

Ana García de Frutos

Ana García de Frutos

Spine Research Unit
Read more
Deborah Pareto Onghena

Deborah Pareto Onghena

Main researcher
Neuroradiology
Read more
Mª Dolores Braquehais Conesa

Mª Dolores Braquehais Conesa

Main researcher
Psychiatry, Mental Health and Addictions
Read more
Laura Castillo Ribelles

Laura Castillo Ribelles

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.